Job Description
The Drug Safety Medical Director works within Drug Safety & Risk Management in Global Pharmacovigilance, providing medical leadership across proactive safety surveillance and lifecycle risk management activities. The role focuses on medical review of Individual Case Safety Reports (ICSRs), safety signal detection and evaluation, and benefit-risk assessment of the assigned products in alignment with general regulatory requirements. The Medical Director partners closely with Pharmacovigilance Scientists and cross‑functional stakeholders to ensure timely, medically sound, and data‑driven safety decisions throughout clinical development and post‑marketing phases.
Primary Responsibilities
- Serves as Medical Reviewer for Individual Case Safety Reports (ICSRs), providing expert medical assessment and clinical judgment.
- Gathers, reviews, and evaluates scientific and clinical data to support the development, maintenance, and update of Company Core Data Sheets (CCDS) and Company Core Safety Information (CCSI).
- Prepares and contributes medical safety content for key regulatory documents, including but not limited to Development Safety Update Reports (DSURs), PSURs/PBRERs, RMPs, and medical expert statements.
- Supports safety signal detection and evaluation activities in collaboration with PV Scientists, applying data‑driven decision‑making throughout the signal management process.
- Authors high‑quality safety review documents, signal evaluation reports, and provides recommendations on risk management actions in partnership with cross‑functional Safety Review Teams.
- Provides medical expertise and collaborates with PV Scientists in the preparation of scientifically robust and regulatory‑compliant responses to safety‑related questions from health authorities.
- Acts as a Subject Matter Expert (SME) for Global Pharmacovigilance and cross‑functional teams, providing guidance on applicable ICH, EU, US, and international clinical development and post‑marketing